98%
921
2 minutes
20
The objective of this study was to evaluate the Amplidiag C. difficile+027 assay, a new molecular method that detects toxin B gene in stool samples and identifies the hypervirulent 027 strain, to diagnose Clostridium difficile infections. The assay was compared to the reference method i.e. toxigenic culture. Amplidiag C. difficile+027 assay was prospectively evaluated from 309 diarrheal stool specimens of patients suspected of C. difficile infection. Forty-five (14.6%) stools were positive by toxigenic culture and 11 (3.6%) stools gave discordant results with the molecular method. PR027 was not recovered during the study. After resolving the discrepant results, the sensitivity, specificity, positive and negative predictive values of Amplidiag C. difficile+027 assay were 91.1% [CI 95% 77.9-97.1], 99.6% [CI 95% 97.6-100], 97.6% [CI 95% 85.9-99.9] and 98.5% [CI 95% 96-99.5], respectively compared to toxigenic culture. This assay is sensitive compared to the toxigenic culture.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.anaerobe.2018.06.012 | DOI Listing |
J Microbiol Biotechnol
September 2025
Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Enterohemorrhagic (EHEC), a pathotype within the Shiga toxin-producing (STEC) group, is a major etiological agent of severe gastrointestinal illness and life-threatening sequelae, including hemolytic uremic syndrome. Although insights into EHEC pathogenesis have been gained through traditional 2D cell culture systems and animal models, these platforms are limited in their ability to recapitulate human-specific physiological responses and tissue-level interactions. Recent progress in three-dimensional (3D) cell culture systems, such as spheroids, organoids, and organ-on-a-chip (OoC) technologies, has enabled more physiologically relevant models for investigating host-pathogen dynamics.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2025
Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
Shiga toxin (Stx)-producing (STEC) harboring virulence determinants of Extraintestinal pathogenic (ExPEC) are currently emerging in Europe as a cause of severe disease. Among the ExPEC features identified in STEC, the gene is associated with an augmented production of Outer Membrane Vesicles (OMV). OMVs produced by strains have been shown to deliver toxins and small RNAs, but information on the latter genetic component is still scanty.
View Article and Find Full Text PDFFoods
July 2025
Ingeniería Agroindustrial, Universidad de las Américas, UDLA, Quito 170513, Ecuador.
Maize is a key crop in Ecuador for both human and animal consumption. Its vulnerability to fungal contamination and mycotoxins poses risks to food safety. The aim of this study was to analyze the occurrence of fungi and mycotoxins in maize grown in different regions of Ecuador (29 localities) and postharvest factors influencing contamination.
View Article and Find Full Text PDFAnaerobe
July 2025
The University of Western Australia, School of Biomedical Sciences, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia; PathWest Laboratory Medicine, Department of Microbiology, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
Background: Despite historically being considered a healthcare-associated pathogen, rates of Clostridioides difficile infection in the community have risen greatly in recent decades. As a pathogen of One Health importance, sources of C. difficile in the community have been sought to understand and control community-associated C.
View Article and Find Full Text PDFAnaerobe
July 2025
Toho University School of Medicine, Department of Microbiology and Infectious Diseases, 5 21 16, Omori-Nishi Ota ku, Tokyo 143-8530, Japan.
Background: To characterize Clostridioides difficile isolates identified during a prospective multi-hospital population-based study of C. difficile infection (CDI).
Methods: Between December 2018 and March 2020, inpatients ≥50 years of age with new-onset diarrhea in nine Tokyo hospitals were investigated for CDI.